252 related articles for article (PubMed ID: 25545162)
1. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.
Denisov IG; Grinkova YV; Baylon JL; Tajkhorshid E; Sligar SG
Biochemistry; 2015 Apr; 54(13):2227-39. PubMed ID: 25777547
[TBL] [Abstract][Full Text] [Related]
3. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
[TBL] [Abstract][Full Text] [Related]
4. Prediction of sites of metabolism in a substrate molecule, instanced by carbamazepine oxidation by CYP3A4.
Yuki H; Honma T; Hata M; Hoshino T
Bioorg Med Chem; 2012 Jan; 20(2):775-83. PubMed ID: 22197672
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.
Denisov IG; Grinkova YV; Nandigrami P; Shekhar M; Tajkhorshid E; Sligar SG
Biochemistry; 2019 Mar; 58(10):1411-1422. PubMed ID: 30785734
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4.
Torimoto N; Ishii I; Hata M; Nakamura H; Imada H; Ariyoshi N; Ohmori S; Igarashi T; Kitada M
Biochemistry; 2003 Dec; 42(51):15068-77. PubMed ID: 14690416
[TBL] [Abstract][Full Text] [Related]
8. Membrane-embedded substrate recognition by cytochrome P450 3A4.
Hackett JC
J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
[TBL] [Abstract][Full Text] [Related]
9. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids.
Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
Drug Metab Dispos; 2003 Apr; 31(4):432-8. PubMed ID: 12642469
[TBL] [Abstract][Full Text] [Related]
10. An epoxidation mechanism of carbamazepine by CYP3A4.
Hata M; Tanaka Y; Kyoda N; Osakabe T; Yuki H; Ishii I; Kitada M; Neya S; Hoshino T
Bioorg Med Chem; 2008 May; 16(9):5134-48. PubMed ID: 18372180
[TBL] [Abstract][Full Text] [Related]
11. Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4.
Rougée LRA; Bedwell DW; Hansen K; Abraham TL; Hall SD
Drug Metab Dispos; 2023 Oct; 51(10):1372-1380. PubMed ID: 37524542
[TBL] [Abstract][Full Text] [Related]
12. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
Sevrioukova IF
J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
[TBL] [Abstract][Full Text] [Related]
13. Binding Specificity Determines the Cytochrome P450 3A4 Mediated Enantioselective Metabolism of Metconazole.
Zhuang S; Zhang L; Zhan T; Lu L; Zhao L; Wang H; Morrone JA; Liu W; Zhou R
J Phys Chem B; 2018 Jan; 122(3):1176-1184. PubMed ID: 29310431
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 1 is required for Carbamazepine-induced CYP3A4 expression.
Wu Y; Shi X; Liu Y; Zhang X; Wang J; Luo X; Wen A
J Pharm Biomed Anal; 2012 Jan; 58():78-82. PubMed ID: 21996064
[TBL] [Abstract][Full Text] [Related]
15. Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems.
Pelkonen O; Myllynen P; Taavitsainen P; Boobis AR; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF
Xenobiotica; 2001 Jun; 31(6):321-43. PubMed ID: 11513246
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of CYP3A4.16: catalytic activities toward midazolam and carbamazepine.
Maekawa K; Yoshimura T; Saito Y; Fujimura Y; Aohara F; Emoto C; Iwasaki K; Hanioka N; Narimatsu S; Niwa T; Sawada J
Xenobiotica; 2009 Feb; 39(2):140-7. PubMed ID: 19255940
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
Sevrioukova IF; Poulos TL
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the
Miyata-Nozaka Y; Zain SM; Taguchi M; Shigeyama M; Isobe T; Hanioka N
Pharmazie; 2017 Dec; 72(12):747-750. PubMed ID: 29441960
[TBL] [Abstract][Full Text] [Related]
19. Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery.
Du H; Li J; Cai Y; Zhang H; Liu G; Tang Y; Li W
J Chem Inf Model; 2017 Mar; 57(3):616-626. PubMed ID: 28221037
[TBL] [Abstract][Full Text] [Related]
20. Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation.
Polic V; Auclair K
Bioconjug Chem; 2017 Apr; 28(4):885-889. PubMed ID: 28339191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
